<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01316393</url>
  </required_header>
  <id_info>
    <org_study_id>HS-10-404</org_study_id>
    <nct_id>NCT01316393</nct_id>
    <nct_alias>NCT01288118</nct_alias>
  </id_info>
  <brief_title>Effects of Mucoprotective Product on Xerostomia</brief_title>
  <official_title>Clinical Evaluation of a Salivary Substitute and a Mucoprotective Product on Xerostomia in Head-and-neck Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Camurus AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Liselott Lindh, Principal Investigator, Prosthetic Dentistry, Malmö University, Malmö, Sweden</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Camurus AB</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the present study with a randomized, cross-over, blind, placebo controlled design, the
      effects of a salivary substitute product and a new mucoprotective product with similar
      mechanisms of action but with different composition and characteristics will be evaluated in
      cancer patients suffering from xerostomia.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>OHIP questionaire health impact profile</measure>
    <time_frame>7 days</time_frame>
    <description>Effect on oral health quality will be assessed after each treatment period</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Xerostomia</condition>
  <arm_group>
    <arm_group_label>XER2020</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mucoprotective product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saliva Natura</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>salivary substitute</description>
  </arm_group>
  <arm_group>
    <arm_group_label>XER2020 placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>XER2020</intervention_name>
    <description>mucoprotective product</description>
    <arm_group_label>XER2020</arm_group_label>
    <arm_group_label>Saliva Natura</arm_group_label>
    <arm_group_label>XER2020 placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. The patient must be at least 18 years of age.

          2. The patient must have clinical symptoms of xerostomia (dry mouth) due to treatment of
             head and neck cancer

          3. The patient must understand and consent in writing to the procedure.

        Exclusion Criteria:

          1. Do not meet the criterion for &quot;dry mouth&quot; regarding saliva secretion threshold values.

          2. Known allergy to ingredients in the products to be used in the trial and/or allergy to
             soy, peanuts, citrus fruit,Yerba Santa or methyl parabene

          3. Patients who are unable or unwilling to cooperate with study procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Prosthetic Dentistry, Malmö University</name>
      <address>
        <city>Malmö</city>
        <zip>SE-21421</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2011</study_first_submitted>
  <study_first_submitted_qc>March 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2011</study_first_posted>
  <last_update_submitted>November 8, 2011</last_update_submitted>
  <last_update_submitted_qc>November 8, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>xerostomia, saliva, mucoprotection, oral health</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Xerostomia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

